33 results
8-K
EX-10.1
CRVS
Corvus Pharmaceuticals, Inc.
6 May 24
Entry into a Material Definitive Agreement
4:11pm
any provision of FCPA.
(v) Cybersecurity. (i) Except as disclosed in the Registration Statement and the Prospectus, to the Company’s knowledge
8-K
EX-1.1
ko1tjro
2 Nov 21
Entry into a Material Definitive Agreement
6:10am
424B5
7e3bgfr01k6vke9c tv
12 Feb 21
Prospectus supplement for primary offering
9:00am
424B5
436v55
11 Feb 21
Prospectus supplement for primary offering
5:14pm